Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

Shaw, R., Yoon, J. J., Johnston, H., Davidson, M. B., Siddon, A. J., Shallis, R. M., Chen, E. C., Burkart, M., Oh, T. S., Iyer, S. G., Madarang, E., Muthiah, C., Kassner, J., Rampal, R. K., Guru Murthy, G. S., Bradley, T. J., Abaza, Y., Garcia, J. S., Gupta, V., … Patel, A. A. (2025). Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy. Blood Advances. https://doi.org/10.1182/bloodadvances.2024015712
Authors:
Reid Shaw
James J Yoon
Hannah Johnston
Marta B Davidson
Alexa J Siddon
Rory M Shallis
Evan Chris Chen
Madelyn Burkart
Timothy S Oh
Sunil Girish Iyer
Ellen Madarang
Chandrasekar Muthiah
Joshua Kassner
Raajit K Rampal
Guru Subramanian Guru Murthy
Terrence J Bradley
Yasmin Abaza
Jacqueline S Garcia
Vikas Gupta
Kristen M Pettit
Olatoyosi Odenike
Anand A Patel
Affiliated Authors:
Sunil Girish Iyer
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2024015712
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: